NEW YORK--([ BUSINESS WIRE ])--[ Medidata Solutions ] (NASDAQ: MDSO), a leading global provider of cloud-based clinical development solutions, today announced that Chairman and CEO Tarek Sherif, President Glen de Vries, and Chief Financial Officer Cory Douglas will participate in three upcoming investor conferences in September.
Deutsche Bank 2012 Technology Conference | ||||
Date: | September 12, 2012, 9:30 am PT | |||
Location: | Las Vegas, NV | |||
Participants: | Tarek Sherif and Cory Douglas | |||
ThinkEquity's 9th Annual Growth Conference (G9) | ||||
Date: | September 13, 2012, 3:30 pm ET | |||
Location: | New York, NY | |||
Participants: | Tarek Sherif and Cory Douglas | |||
Credit Suisse 3rd Annual Small and Mid Cap Conference | ||||
Date: | September 21, 2012, 9:20 am ET | |||
Location: | New York, NY | |||
Participants: | Glen de Vries and Cory Douglas |
Live audio webcasts will be available for the Deutsche Bank 2012 Technology Conference and ThinkEquityas 9th Annual Growth Conference on the aInvestora section of Medidataas website at [ http://investor.mdsol.com ]. Please visit the website at least 15 minutes prior to each event to register, download and install any necessary audio or video software to access the presentation. For those unable to participate in the live webcasts, replays will be archived on the aInvestora section of Medidataas website at [ http://investor.mdsol.com ] for a limited period of time following the conferences.
About Medidata Solutions Worldwide
[ Medidata Solutions ] is a leading global provider of cloud-based clinical development solutions that enhance the efficiency of customersa clinical trials. Medidataas advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion: from study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding to business analytics. Our diverse life science customer base spans biopharmaceutical companies, medical device and diagnostic companies, academic and government institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies as well as organizations of all sizes developing life-enhancing medical treatments and diagnostics.